Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Date:5/18/2010

period in 2009. Sales of Sinofuan constituted 5.5% of the Company's product revenue for the first quarter of 2010.

Revenue from other first-to-market products including Jiebaishu, a nedaplatin product, and Anxin, a biapenem injection, increased by 12.7% to RMB8.7 million (US$1.3 million) from RMB7.7 million for the same period in 2009. Sale of other first-to-market products constituted 1.9% of the Company's product revenue for the first quarter of 2010.

Revenue from other branded generic products including Zailin and Yingtaiqing decreased by 10.4% to RMB186.2 million (US$27.3 million) from RMB207.7 million for the same period in 2009. Sales of other branded generic products constituted 40.7% of the Company's product revenue for the first quarter of 2010.

Gross margin for the first quarter of 2010 decreased to 79.7% compared to 82.5% for the same period in 2009. The decrease was primarily due to a decline in other revenue from RMB5.8 million for the first quarter of 2009 to RMB1.0 million (US$0.2 million) for this quarter as well as lower revenue and gross margin contribution from Jiangsu Yanshen. Other revenue was primarily comprised of government subsidies and VAT refund.

Research and development expenses for the first quarter of 2010 totaled RMB30.6 million (US$4.5 million) which represented an increase of 22.1% from RMB25.0 million for the same period in 2009. This increase was due primarily to the increased expenditure on on-going research and development proje
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Simceres Diosmectite API Passes EU-GMP Inspection
2. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
3. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
4. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
7. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
8. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
9. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
11. Isis Pharmaceuticals to Discuss Its Cancer Franchise in a Conference Call on Wednesday, May 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015 China,s ... Fetus Monitoring Patch, a wearable medical device that can ... movement data, providing safety guidance for pregnant women. The ... The device, which measures 4 centimeters in diameter, ... a little more than an Apple earphone cord. The ...
(Date:9/3/2015)... , Sept. 3, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Wells Fargo Healthcare Conference at 8:50 a.m. ET on ... 9-10, 2015 at The Hyatt Regency, Boston ...
(Date:9/3/2015)... , Sept. 3, 2015  The findings of a ... disturbing questions about the company,s handling of its ... On September 2 nd , part one of ... events, including at least 27 fatalities, have been associated ... confidential study commissioned by C.R. Bard in 2004 which ...
Breaking Medicine Technology:Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3
... to be Presented for Phase 2 Colorectal and Prostate ... May 31 with Oncology Experts - SOUTH SAN FRANCISCO, ... PARD ) today announced that the Company will ... trials of picoplatin, the Company,s lead product candidate, at ...
... This Trial to be Presented at ASCO--First Phase ... Patient Enrollment-TUSTIN, Calif., May 4 Peregrine Pharmaceuticals, ... it has completed enrollment in its Phase II ... advanced breast cancer patients. The planned 46 ...
Cached Medicine Technology:Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 2Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 3Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 4Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients 3Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients 4
(Date:9/3/2015)... Lawrenceville, Georgia (PRWEB) , ... September 03, 2015 ... ... the spread of disease in Haiti, has partnered with Slingshot® Product Development Group ... no electricity or running water. Michael Wahl with DriButts plans to bring 600 ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
(Date:9/3/2015)... Tamarac, FL (PRWEB) , ... September 03, 2015 ... ... of the Florida Companies to Watch for 2015 by economic development ... one of only 50 companies in the state selected for this prestigious award, ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... estate investment landscape by connecting accredited and institutional investors to real estate investment ... products designed to meet demand from both investors and sponsoring real estate companies. ...
(Date:9/3/2015)... ... ... Girl’s Night Out to benefit Core Compassion Project will be held on ... Monroe, North Carolina. The event food will be provided by Kate Clyde's ... off-premise catering and event services from casual to elegant. They are also the home ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2
... stray cancer cells lurking elsewhere in the body that otherwise ... study in the June 13 issue of the journal ... most may have such indolent cancer cells given the sheer ... them impossible to detect, the researchers said. , The ...
... his famous poem, "Do not go gentle into that good ... dying of the light." Researchers are now backing up this ... to one,s health is critical to good health and survival ... the notion that one should become actively involved in one,s ...
... Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that it ... its Trofex molecular imaging program for the detection ... is designed to investigate two small molecule radiopharmaceutical ... and MIP-1095, in order to select a lead ...
... Foundation, a,nonprofit organization that funds research in early ... five recipients of its Canary,Foundation and American Cancer ... during Canary Foundation,s Early,Detection Symposium in May, the ... of fellows sponsored since the program,s inception in,2004. ...
... supports Courage Center Camps, MINNEAPOLIS, June 12 The ... 2008, at the St. Cloud Country Club. Golfers,will enjoy a ... a,great cause -- Courage Center,s Camp Courage., Registration and ... 1 p.m.,Cost per golfer is $150 or $600 for a ...
... and Life Sciences Customers the DICOM ... EMC Select, ST. PAUL, Minn., June 12 ... grid software for,intelligent medical image management, DICOM and storage ... announced that its DICOM,Services Grid is now available through ...
Cached Medicine News:Health News:Primary tumors can drive the growth of distant cancers 2Health News:Primary tumors can drive the growth of distant cancers 3Health News:Study pinpoints strategies that protect older adult's physical health 2Health News:Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 3Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 4Health News:DICOM Services Grid(TM) From Acuo Technologies(R) Available Through EMC Select 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: